RYHIX Holdings — Health Care Fund
All 135 reported holdings of Health Care Fund (RYHIX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Company | 3.63% | $705.26K |
| Johnson & Johnson | 2.88% | $559.50K |
| Abbvie, Inc. | 2.52% | $489.44K |
| Unitedhealth Group, Inc. | 2.22% | $431.01K |
| Merck & Company, Inc. | 2.04% | $396.17K |
| Thermo Fisher Scientific, Inc. | 1.61% | $311.85K |
| Amgen, Inc. | 1.56% | $302.37K |
| Abbott Laboratories | 1.42% | $274.94K |
| Gilead Sciences, Inc. | 1.39% | $269.36K |
| Vertex Pharmaceuticals, Inc. | 1.34% | $259.29K |
| Cvs Health Corp. | 1.31% | $254.38K |
| Intuitive Surgical, Inc. | 1.31% | $254.12K |
| Danaher Corp. | 1.30% | $252.58K |
| Pfizer, Inc. | 1.25% | $242.97K |
| Bristol-Myers Squibb Company | 1.22% | $236.30K |
| Stryker Corp. | 1.21% | $235.19K |
| Mckesson Corp. | 1.05% | $204.01K |
| Elevance Health, Inc. | 1.02% | $198.78K |
| Cigna Group (the) | 0.94% | $181.67K |
| Regeneron Pharmaceuticals, Inc. | 0.90% | $175.21K |
| Hca Healthcare, Inc. | 0.87% | $169.60K |
| Cardinal Health, Inc. | 0.86% | $166.77K |
| Boston Scientific Corp. | 0.86% | $166.54K |
| Edwards Lifesciences Corp. | 0.84% | $162.29K |
| Novo Nordisk A/s | 0.83% | $160.60K |
| Cencora, Inc. | 0.82% | $159.03K |
| Humana, Inc. | 0.81% | $156.50K |
| Medtronic PLC | 0.78% | $150.59K |
| Natera, Inc. | 0.77% | $150.11K |
| Revolution Medicines, Inc. | 0.76% | $148.51K |
| Becton Dickinson & Company | 0.74% | $144.07K |
| Icon PLC | 0.73% | $142.62K |
| Alnylam Pharmaceuticals, Inc. | 0.73% | $141.18K |
| Agilent Technologies, Inc. | 0.71% | $138.14K |
| Waters Corp. | 0.71% | $137.26K |
| Idexx Laboratories, Inc. | 0.70% | $135.82K |
| Argenx SE | 0.69% | $134.53K |
| Beone Medicines Ltd. | 0.67% | $130.23K |
| Jazz Pharmaceuticals PLC | 0.67% | $129.88K |
| Iqvia Holdings, Inc. | 0.66% | $128.88K |
| Moderna, Inc. | 0.66% | $128.72K |
| Biogen, Inc. | 0.66% | $127.48K |
| Centene Corp. | 0.65% | $125.94K |
| Alkermes PLC | 0.65% | $125.75K |
| Royalty Pharma PLC | 0.62% | $120.55K |
| Mettler-Toledo International, Inc. | 0.61% | $118.81K |
| Ge Healthcare Technologies, Inc. | 0.61% | $117.91K |
| Veeva Systems, Inc. | 0.61% | $117.84K |
| Resmed, Inc. | 0.60% | $116.93K |
| Illumina, Inc. | 0.60% | $115.87K |
| Astrazeneca PLC | 0.60% | $115.86K |
| West Pharmaceutical Services, Inc. | 0.59% | $115.24K |
| Teva Pharmaceutical Industries Ltd. | 0.59% | $114.79K |
| Gsk PLC | 0.59% | $113.86K |
| Crispr Therapeutics AG | 0.58% | $111.86K |
| Biontech SE | 0.57% | $111.29K |
| Quest Diagnostics, Inc. | 0.56% | $108.52K |
| Labcorp Holdings, Inc. | 0.56% | $108.36K |
| Novartis AG | 0.56% | $107.82K |
| Zoetis, Inc. | 0.55% | $107.72K |
| Insmed, Inc. | 0.55% | $107.26K |
| Dexcom, Inc. | 0.54% | $105.54K |
| United Therapeutics Corp. | 0.53% | $103.49K |
| Guardant Health, Inc. | 0.53% | $103.07K |
| Ascendis Pharma A/s | 0.53% | $102.95K |
| Alcon AG | 0.52% | $100.78K |
| Steris PLC | 0.52% | $100.02K |
| Roivant Sciences Ltd. | 0.51% | $99.38K |
| Incyte Corp. | 0.50% | $96.92K |
| Viatris, Inc. | 0.48% | $93.03K |
| Neurocrine Biosciences, Inc. | 0.47% | $91.35K |
| Zimmer Biomet Holdings, Inc. | 0.46% | $89.19K |
| Tenet Healthcare Corp. | 0.46% | $88.86K |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 0.45% | $88.28K |
| J.p. Morgan Securities LLC | 0.45% | $88.28K |
| Cooper Companies, Inc. (the) | 0.44% | $84.55K |
| Molina Healthcare, Inc. | 0.43% | $83.70K |
| Bio-Techne Corp. | 0.43% | $83.23K |
| Bridgebio Pharma, Inc. | 0.43% | $82.90K |
| Ionis Pharmaceuticals, Inc. | 0.42% | $81.03K |
| Cytokinetics, Inc. | 0.42% | $80.85K |
| Revvity, Inc. | 0.42% | $80.77K |
| Exelixis, Inc. | 0.41% | $79.71K |
| Charles River Laboratories International, Inc. | 0.41% | $79.38K |
| Elanco Animal Health, Inc. | 0.39% | $76.59K |
| Medpace Holdings, Inc. | 0.39% | $75.20K |
| Arrowhead Pharmaceuticals, Inc. | 0.39% | $74.83K |
| Biomarin Pharmaceutical, Inc. | 0.38% | $74.27K |
| Align Technology, Inc. | 0.38% | $73.87K |
| Baxter International, Inc. | 0.38% | $73.85K |
| Insulet Corp. | 0.37% | $71.86K |
| Ensign Group, Inc. (the) | 0.36% | $70.53K |
| Halozyme Therapeutics, Inc. | 0.36% | $70.21K |
| Vaxcyte, Inc. | 0.36% | $69.29K |
| Axsome Therapeutics, Inc. | 0.35% | $68.29K |
| Krystal Biotech, Inc. | 0.35% | $67.64K |
| Hims & Hers Health, Inc. | 0.34% | $65.60K |
| Tg Therapeutics, Inc. | 0.33% | $64.94K |
| Universal Health Services, Inc. | 0.33% | $64.53K |
| Henry Schein, Inc. | 0.33% | $63.73K |
| Protagonist Therapeutics, Inc. | 0.33% | $63.37K |
| Corcept Therapeutics, Inc. | 0.32% | $62.78K |
| Tempus Ai, Inc. | 0.32% | $61.70K |
| Healthequity, Inc. | 0.31% | $60.60K |
| Repligen Corp. | 0.31% | $59.76K |
| Lantheus Holdings, Inc. | 0.31% | $59.57K |
| Ptc Therapeutics, Inc. | 0.30% | $59.06K |
| Scholar Rock Holding Corp. | 0.30% | $58.91K |
| Madrigal Pharmaceuticals, Inc. | 0.30% | $57.99K |
| Avantor, Inc. | 0.30% | $57.71K |
| Bruker Corp. | 0.30% | $57.53K |
| Mirum Pharmaceuticals, Inc. | 0.28% | $54.09K |
| Viking Therapeutics, Inc. | 0.28% | $53.72K |
| Praxis Precision Medicines, Inc. | 0.27% | $52.56K |
| Rhythm Pharmaceuticals, Inc. | 0.27% | $52.30K |
| Indivior Pharmaceuticals, Inc. | 0.26% | $50.59K |
| Alignment Healthcare, Inc. | 0.25% | $49.10K |
| Radnet, Inc. | 0.24% | $46.75K |
| Ultragenyx Pharmaceutical, Inc. | 0.24% | $46.18K |
| Merit Medical Systems, Inc. | 0.23% | $45.14K |
| Acadia Pharmaceuticals, Inc. | 0.22% | $42.73K |
| Option Care Health, Inc. | 0.21% | $40.26K |
| Acadia Healthcare Company, Inc. | 0.20% | $38.33K |
| Waystar Holding Corp. | 0.19% | $36.28K |
| Recursion Pharmaceuticals, Inc. | 0.17% | $32.80K |
| Sarepta Therapeutics, Inc. | 0.17% | $32.54K |
| Dentsply Sirona, Inc. | 0.17% | $32.53K |
| Summit Therapeutics, Inc. | 0.16% | $31.85K |
| Transmedics Group, Inc. | 0.16% | $30.69K |
| Adma Biologics, Inc. | 0.16% | $30.14K |
| Irhythm Holdings, Inc. | 0.13% | $25.10K |
| Genedx Holdings Corp. | 0.12% | $23.14K |
| Dreyfus Treasury Obligations Cash Management | 0.02% | $3.53K |
| Jnj Cvr | 0.00% | $0 |
| Sanofi SA - Cvr | 0.00% | $0 |
RYHIX overview: performance, fees, allocation and SEC filings